Shulman Joseph bought RYTM
August 13, 2026 · Form 4 insider transaction
Shulman Joseph bought 2,024 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $13.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,024
Price
$6.80
Total value
$13.8K
InsiderShulman Joseph
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2026
Filing dateAugust 17, 2026
Shares owned after20,994
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The Exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.